Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.verified

NWBO

Price:

$0.3189

Market Cap:

$398.06M

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.[Read more]

Industry

Biotechnology

IPO Date

2001-12-14

Stock Exchange

PNK

Ticker

NWBO

The PE Ratio as of September 2024 (TTM) for Northwest Biotherapeutics, Inc. (NWBO) is -4.56

According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.56. This represents a change of -53.98% compared to the average of -9.91 of the last 4 quarters.

Northwest Biotherapeutics, Inc. (NWBO) Historical PE Ratio (quarterly & annually)

How has NWBO PE Ratio performed in the past?

The mean historical PE Ratio of Northwest Biotherapeutics, Inc. over the last ten years is -3.05. The current -4.56 PE Ratio has changed 14.86% with respect to the historical average. Over the past ten years (40 quarters), NWBO's PE Ratio was at its highest in in the June 2019 quarter at 163.32. The PE Ratio was at its lowest in in the March 2021 quarter at -75.40.

Quarterly (TTM)
Annual

Average

-3.05

Median

-2.25

Minimum

-12.61

Maximum

3.41

Northwest Biotherapeutics, Inc. (NWBO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 223.97%

Maximum Annual PE Ratio = 3.41

Minimum Annual Increase = -270.60%

Minimum Annual PE Ratio = -12.61

Quarterly (TTM)
Annual
YearPE RatioChange
2023-12.61116.56%
2022-5.82-270.60%
20213.41-265.65%
2020-2.06-59.00%
2019-5.0394.70%
2018-2.58223.97%
2017-0.8064.41%
2016-0.48-77.64%
2015-2.17-7.26%
2014-2.3424.09%

Northwest Biotherapeutics, Inc. (NWBO) Average PE Ratio

How has NWBO PE Ratio performed in the past?

The current PE Ratio of Northwest Biotherapeutics, Inc. (NWBO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-5.01

5-year avg

-4.42

10-year avg

-3.05

Northwest Biotherapeutics, Inc. (NWBO) PE Ratio vs. Peers

How is NWBO’s PE Ratio compared to its peers?

Northwest Biotherapeutics, Inc.’s PE Ratio is less than ImmunoCellular Therapeutics, Ltd. (0), greater than Celldex Therapeutics, Inc. (-18.12), less than CEL-SCI Corporation (-2.05), less than OncoSec Medical Incorporated (-0.05), less than Advaxis, Inc. (-0.01),

Build a custom stock screener for Northwest Biotherapeutics, Inc. (NWBO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Northwest Biotherapeutics, Inc. (NWBO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Northwest Biotherapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Northwest Biotherapeutics, Inc. (NWBO)?

What is the highest PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?

What is the 3-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?

What is the 5-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?

How does the current PE Ratio for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?